Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Maybe a faster response saves medical expenses, not to mention patient trauma and possible long term damage.
Interesting news! Every advance for stem cell therapy reflects positively for Pluristem's future outlook. Thanks for the link.
GF, you're much sharper than I thought!
You caught my typo below, congrats!
I assume that's a rhetorical question.
This is a very strange day! First we go up (pre market), presumably on expectations of (good) news. Then we have no news... so I would expect disappointment and some selling from the more fickle nervous investors.
But, instead we get a fairly normal day, as if there's nothing unususal was going on (like no announcement on the day we expected the FDA response).
I draw no conclusion from any of this. I just have to assume that an excellent P3 and a superior drug WILL get us to approval.
Thanks for the tip!
As for the GF, swatting at individuals who post only to irritate (what a sad form of entertainment) is my pleasure and privilege.
BTW, I share you optimism and I do hope we get the extended protection.